- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 313/06 - Sulfinamides
Patent holdings for IPC class C07C 313/06
Total number of patents in this class: 62
10-year publication summary
|
4
|
6
|
4
|
5
|
6
|
6
|
6
|
9
|
2
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Peloton Therapeutics, Inc. | 38 |
4 |
| Nikang Therapeutics, Inc. | 110 |
4 |
| Orsobio, Inc. | 19 |
4 |
| Novartis AG | 10174 |
3 |
| Vitae Pharmaceuticals, Inc. | 86 |
3 |
| Oxford Drug Design Limited | 11 |
3 |
| Boehringer Ingelheim International GmbH | 4488 |
2 |
| Alkermes Pharma Ireland Limited | 255 |
2 |
| Cytokinetics, Inc. | 251 |
2 |
| Gilgamesh Pharmaceuticals, Inc. | 66 |
2 |
| Piramal Pharma Limited | 55 |
2 |
| The Regents of the University of California | 20868 |
1 |
| Genentech, Inc. | 4123 |
1 |
| Bayer Intellectual Property GmbH | 2353 |
1 |
| FUJIFILM Corporation | 30653 |
1 |
| Ricoh Company, Ltd. | 13355 |
1 |
| ABX Advanced Biochemical Compounds GmbH | 12 |
1 |
| Amira Pharmaceuticals, Inc. | 66 |
1 |
| Arbutus Biopharma Corporation | 161 |
1 |
| Kinex Pharmaceuticals, LLC | 9 |
1 |
| Other owners | 22 |